[The leukocyte adherence inhibition reaction in patients with acute leukemia]. 1988

N L Vartanian, and I S Luganova, and M N Blinov

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007957 Leukocyte Adherence Inhibition Test Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor. LAI Test,LAI Tests,Test, LAI,Tests, LAI
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

N L Vartanian, and I S Luganova, and M N Blinov
January 1983, Rivista di emoterapia ed immunoematologia,
N L Vartanian, and I S Luganova, and M N Blinov
January 1982, Revista espanola de oncologia,
N L Vartanian, and I S Luganova, and M N Blinov
January 1979, Voprosy onkologii,
N L Vartanian, and I S Luganova, and M N Blinov
August 1988, Scandinavian journal of dental research,
N L Vartanian, and I S Luganova, and M N Blinov
April 1985, Rinsho byori. The Japanese journal of clinical pathology,
N L Vartanian, and I S Luganova, and M N Blinov
January 1986, Voprosy onkologii,
N L Vartanian, and I S Luganova, and M N Blinov
February 1979, Cancer research,
N L Vartanian, and I S Luganova, and M N Blinov
May 1978, Biulleten' eksperimental'noi biologii i meditsiny,
N L Vartanian, and I S Luganova, and M N Blinov
January 1983, Arerugi = [Allergy],
Copied contents to your clipboard!